Research Archive — Page 1 of 138
-
October 7, 2026
Monroe Carell Jr. Children’s Hospital at Vanderbilt leads breakthrough heart recovery method for pediatric transplants
Surgeons reported using the novel technique known as REUP (rapid recovery with extended ultraoxygenated preservation) to transplant five donor hearts in children. Since then, five more children were saved successfully. -
October 7, 2026
An extremely old giant tortoise named Jonathan may hold the secret to a long, healthy life: Study
Jonathan’s secret involves entropy, the tendency of biological systems to become disordered over time. -
October 6, 2026
Behind eMERGE’s genetic risk reports, a data platform built at Vanderbilt Health
A recent study shows what's involved in bringing polygenic risk to bear in chronic disease clinical decision-making. -
October 6, 2026
Vanderbilt Health to lead initiative to get genomics toward the clinic via machine learning and AI
There are many more known pathogenic gene variants than there are clinical solutions for dealing with them. A new Vanderbilt Health-led NIH-funded research consortium will use machine learning and AI to help usher in genome-informed clinical decision support. -
October 5, 2026
Vanderbilt Health to lead national consortium on life-threatening drug reactions of the skin
“For too long, patients who survive these reactions have been left without clear answers about why it happened, which medicines are safe, and what the future holds,” said Elizabeth Phillips, MD, who is leading the consortium. -
October 5, 2026
Human trial: Popular diabetes drug shown to lower inflammation, which may protect the heart
Individuals taking the drug saw a significant drop in inflammatory cell clumps within just two weeks, and the reduction grew even stronger by week 12. -
September 28, 2026
California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing
The human monoclonal antibodies were isolated from two individuals who had been infected by measles. Further development and clinical testing could lead to the first monoclonal antibody therapy against the highly infectious respiratory virus.